aspirin has been researched along with Aneuploid in 3 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risk for preterm preeclampsia (<37 weeks) was calculated using the Fetal Medicine Foundation algorithm, and individuals with a risk score ≥1 per 100 were recommended to use aspirin (162 mg once daily at bedtime, <16-36 weeks)." | 1.91 | The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study. ( Chada, R; Dwinnell, SJ; Johnson, DW; Johnson, JM; Kuret, VH; Mahallati, H; Maxey, CM; Metcalfe, A; Nerenberg, KA; O'Quinn, CP; Okun, NB; Pastuck, ML; Paterson, K; Paul, H; Schacher, J; Silang, KA; Soliman, N; Somerset, DA; Suchet, IB; Walsh, JD, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, JM | 3 |
| Walsh, JD | 3 |
| Okun, NB | 3 |
| Metcalfe, A | 3 |
| Pastuck, ML | 3 |
| Maxey, CM | 3 |
| Soliman, N | 3 |
| Mahallati, H | 3 |
| Kuret, VH | 3 |
| Dwinnell, SJ | 3 |
| Chada, R | 3 |
| O'Quinn, CP | 3 |
| Schacher, J | 3 |
| Somerset, DA | 3 |
| Paterson, K | 3 |
| Suchet, IB | 3 |
| Silang, KA | 3 |
| Paul, H | 3 |
| Nerenberg, KA | 3 |
| Johnson, DW | 3 |
| Pyeon, SY | 1 |
| Kwon, BS | 1 |
| Kim, YS | 1 |
| Lee, YJ | 1 |
| Urman, B | 1 |
| Yakin, K | 1 |
| Balaban, B | 1 |
1 review available for aspirin and Aneuploid
| Article | Year |
|---|---|
Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple.
Topics: Aneuploidy; Antibodies, Antiphospholipid; Aspirin; Blade Implantation; Embryo Culture Techniques; Em | 2005 |
2 other studies available for aspirin and Aneuploid
| Article | Year |
|---|---|
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study.
Topics: Aneuploidy; Aspirin; Canada; Female; Humans; Infant, Newborn; Placenta Growth Factor; Pre-Eclampsia; | 2023 |
Diagnostic efficacy of aneuploidy markers correlated with early onset preeclampsia.
Topics: alpha-Fetoproteins; Aneuploidy; Aspirin; Biomarkers; Chorionic Gonadotropin; Chorionic Gonadotropin, | 2022 |